INS and cancer: Both cancer cell extrinsic influences, such as systemic increases in insulin, and inter-cellular heterogeneity between cancer cells are likely to be factors limiting the efficacy of the therapy, with one possibility being that a subset of cells persist under PI3K pathway inhibition by regulating glycolysis through other mechanisms (Hopkins et al., 2018; Liu et al., 2011).